Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)

NCT00235690 ·Status: COMPLETED ·Phase: NA

Detection of Colistin-resistant Isolates From Patients of Intensive Care Units and Oncohaematology Wards.

NCT03971877 ·Status: COMPLETED

Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria

NCT01060891 ·Status: COMPLETED ·Phase: PHASE1

Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections

NCT05942157 ·Status: RECRUITING ·Phase: NA

Safety and Efficacy Study of High Dose Colistin

NCT02162966 ·Status: UNKNOWN ·Phase: PHASE4

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

NCT01597973 ·Status: COMPLETED ·Phase: PHASE3

Gram Negative Bacteremia, Risk Factors for Failure of Therapy

NCT00177957 ·Status: COMPLETED

Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections

NCT06843668 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar

NCT06218277 ·Status: COMPLETED ·Phase: NA

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

NCT03397914 ·Status: COMPLETED ·Phase: PHASE4

Predictors of Rates of Resistant Gram-Negative Bacteria

NCT01075009 ·Status: COMPLETED

Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient Setting

NCT03612297 ·Status: UNKNOWN

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

NCT05210387 ·Status: TERMINATED ·Phase: NA

Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium

NCT02288429 ·Status: COMPLETED

Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.

NCT04995133 ·Status: UNKNOWN ·Phase: PHASE4

Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)

NCT01292031 ·Status: COMPLETED ·Phase: PHASE3

Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin

NCT02619786 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

NCT00300560 ·Status: UNKNOWN ·Phase: PHASE3

Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections

NCT00427076 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection

NCT05586815 ·Status: UNKNOWN ·Phase: PHASE4

Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection

NCT06570850 ·Status: RECRUITING ·Phase: PHASE4

Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline

NCT06893835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem

NCT01732250 ·Status: COMPLETED ·Phase: PHASE4

Nebulized Colistin for Gram Negative VAP Prevention.

NCT04208945 ·Status: UNKNOWN ·Phase: NA

Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia

NCT01737320 ·Status: COMPLETED ·Phase: NA